Cargando…
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
Stroke is a major cause of death and long-term disability in industrialized countries, and the only causal therapy for stroke comprises recombinant tissue plasminogen activator(rt-PA)-mediated recanalization of the occluded vessel. New experimental strategies focus on neuroregenerative approaches, a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781740/ https://www.ncbi.nlm.nih.gov/pubmed/24198521 http://dx.doi.org/10.2147/SCCAA.S7820 |